Maravai LifeSciences Holdings Inc (MRVI)
7.85
+0.08
(+1.03%)
USD |
NASDAQ |
Nov 05, 16:00
7.85
0.00 (0.00%)
After-Hours: 19:02
Maravai LifeSciences Holdings Revenue (Quarterly): 73.40M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 73.40M |
| March 31, 2024 | 64.18M |
| December 31, 2023 | 74.14M |
| September 30, 2023 | 66.86M |
| June 30, 2023 | 68.91M |
| March 31, 2023 | 79.02M |
| December 31, 2022 | 204.71M |
| September 30, 2022 | 191.26M |
| June 30, 2022 | 242.73M |
| March 31, 2022 | 244.29M |
| Date | Value |
|---|---|
| December 31, 2021 | 228.44M |
| September 30, 2021 | 204.81M |
| June 30, 2021 | 217.78M |
| March 31, 2021 | 148.21M |
| December 31, 2020 | 98.35M |
| September 30, 2020 | 87.86M |
| June 30, 2020 | 46.90M |
| March 31, 2020 | 50.98M |
| December 31, 2019 | 35.96M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
35.96M
Minimum
Dec 2019
244.29M
Maximum
Mar 2022
127.83M
Average
87.86M
Median
Sep 2020
Revenue (Quarterly) Benchmarks
| Repligen Corp | 154.07M |
| Evoke Pharma Inc | 2.551M |
| Personalis Inc | 22.58M |
| Tempus AI Inc | 165.97M |
| Codexis Inc | 12.83M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.585M |
| Total Expenses (Quarterly) | 84.11M |
| EPS Diluted (Quarterly) | -0.05 |
| Enterprise Value | 1.389B |
| Gross Profit Margin (Quarterly) | 47.86% |
| Profit Margin (Quarterly) | -10.33% |
| Earnings Yield | -12.61% |
| Normalized Earnings Yield | -12.39 |